My view has not changed: BPC-157 lacks adequate human evidence for ulcerative colitis, Crohn's disease or "gut healing", and it should not replace established IBD treatment
Fast Answer GHK-Cu peptide is a copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine that is studied mainly for skin biology, collagen synthesis, wound healing, and related dermatology uses [1], [2]
57.5 mg Phosphatidylcholine (from highly purified phospholipids)
All treatment decisions are made solely by your licensed provider based on your individual clinical profile
Lee A, Hirabayashi Y, Kwon SK, Lewis TL Jr., Polleux F
Over 40 years of research and clinical use have established that it is well tolerated with minimal adverse effects at recommended doses